Ryan Specialty has announced the integration of Paradiso Risks into Alive Risk, its sports, leisure and entertainment (SLE) managing general underwriter. Paradiso, specialising in contingency and ...
With more efficient portfolio risk analytics, you can save time and test your hypotheses faster. Quickly peel apart the holdings in managed investments, models, ETFs, custom benchmarks ...
The U.S. FDA smacked Lexicon Pharmaceuticals Inc. with a complete response letter regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for glycemic control in adults with ...